- Home
- ILPT vs ABEO Comparison
ILPT vs ABEO Comparison
Compare ILPT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- ABEO
- Stock Information
- Founded
- ILPT 2017
- ABEO N/A
- Country
- ILPT United States
- ABEO United States
- Employees
- ILPT N/A
- ABEO N/A
- Industry
- ILPT Real Estate Investment Trusts
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- ILPT Real Estate
- ABEO Health Care
- Exchange
- ILPT Nasdaq
- ABEO Nasdaq
- Market Cap
- ILPT 262.6M
- ABEO 237.4M
- IPO Year
- ILPT 2018
- ABEO 1980
- Fundamental
- Price
- ILPT $2.61
- ABEO $4.84
- Analyst Decision
- ILPT Buy
- ABEO Strong Buy
- Analyst Count
- ILPT 2
- ABEO 5
- Target Price
- ILPT $10.00
- ABEO $17.00
- AVG Volume (30 Days)
- ILPT 510.5K
- ABEO 821.9K
- Earning Date
- ILPT 04-29-2025
- ABEO 05-14-2025
- Dividend Yield
- ILPT 1.52%
- ABEO N/A
- EPS Growth
- ILPT N/A
- ABEO N/A
- EPS
- ILPT N/A
- ABEO N/A
- Revenue
- ILPT $442,322,000.00
- ABEO N/A
- Revenue This Year
- ILPT $8.07
- ABEO N/A
- Revenue Next Year
- ILPT N/A
- ABEO $539.93
- P/E Ratio
- ILPT N/A
- ABEO N/A
- Revenue Growth
- ILPT 1.14
- ABEO N/A
- 52 Week Low
- ILPT $2.45
- ABEO $3.05
- 52 Week High
- ILPT $5.45
- ABEO $8.45
- Technical
- Relative Strength Index (RSI)
- ILPT 32.51
- ABEO 49.29
- Support Level
- ILPT $2.50
- ABEO $3.93
- Resistance Level
- ILPT $2.71
- ABEO $5.02
- Average True Range (ATR)
- ILPT 0.21
- ABEO 0.41
- MACD
- ILPT -0.05
- ABEO 0.06
- Stochastic Oscillator
- ILPT 14.22
- ABEO 83.49
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.